Role of AMPA and GluR5 kainate receptors in the development and expression of amygdala kindling in the mouse (Q31561622)

2 July 2017

Role of AMPA and GluR5 kainate receptors in the development and expression of amygdala kindling in the mouse (English)

1 reference

2 July 2017

1 reference

Rogawski MA

1

1 reference

2 July 2017

Kurzman PS

series ordinal

2

1 reference

2 July 2017

Yamaguchi SI

series ordinal

3

1 reference

2 July 2017

Li H

series ordinal

4

1 reference

2 July 2017

1 January 2001

1 reference

2 July 2017

1 reference

2 July 2017

40

1 reference

2 July 2017

1

1 reference

2 July 2017

28-35

1 reference

Pharmacological characterization of a GluR6 kainate receptor in cultured hippocampal neurons

2 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900112-X

Kainate receptors are involved in synaptic plasticity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900112-X

The anticonvulsant effect of the non-NMDA antagonists, NBQX and GYKI 52466, in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900112-X

A hippocampal GluR5 kainate receptor regulating inhibitory synaptic transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900112-X

7-Chlorokynurenic acid, a strychnine-insensitive glycine receptor antagonist, inhibits limbic seizure kindling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900112-X

GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900112-X

The effect of the non-NMDA receptor antagonist GYKI 52466 and NBQX and the competitive NMDA receptor antagonist D-CPPene on the development of amygdala kindling and on amygdala-kindled seizures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900112-X

The neuroprotective effects of the decahydroisoquinoline, LY 215490; a novel AMPA antagonist in focal ischaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900112-X

A permanent change in brain function resulting from daily electrical stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900112-X

The N-methyl-D-aspartate antagonists aminophosphonovalerate and carboxypiperazinephosphonate retard the development and expression of kindled seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900112-X

Effects of YM90K, a selective AMPA receptor antagonist, on amygdala-kindling and long-term hippocampal potentiation in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900112-X

GluR5 kainate receptor mediated synaptic transmission in rat basolateral amygdala in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900112-X

Pharmacology of glutamate receptor antagonists in the kindling model of epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900112-X

Effects of competitive and noncompetitive NMDA receptor antagonists on kindling and LTP

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900112-X

Antiepileptogenic and anticonvulsant effects of NBQX, a selective AMPA receptor antagonist, in the rat kindling model of epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900112-X

Decahydroisoquinolines: novel competitive AMPA/kainate antagonists with neuroprotective effects in global cerebral ischaemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900112-X

(3SR,4aRS,6RS,8aRS)-6-[2-(1H-tetrazol-5-yl)ethyl]decahydroisoquinoline-3 - carboxylic acid: a structurally novel, systemically active, competitive AMPA receptor antagonist.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900112-X

Selective antagonism of AMPA receptors unmasks kainate receptor-mediated responses in hippocampal neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900112-X

Modification of seizure activity by electrical stimulation. II. Motor seizure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900112-X

Anticonvulsant action of a non-competitive antagonist of NMDA receptors (MK-801) in the kindling model of epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900112-X

In vitro and in vivo antagonism of AMPA receptor activation by (3S, 4aR, 6R, 8aR)-6-[2-(1(2)H-tetrazole-5-yl) ethyl] decahydroisoquinoline-3-carboxylic acid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900112-X

Kainate GluR5 receptor subtype mediates the nociceptive response to formalin in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900112-X

Anticonvulsant activity of AMPA/kainate antagonists: comparison of GYKI 52466 and NBOX in maximal electroshock and chemoconvulsant seizure models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900112-X

10.1016/S0028-3908(00)00112-X

7 January 2021

Identifiers

DOI

1 reference

2 July 2017

1 reference